Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-11

Clinical Trial Update: Nebivolol in Patients With Systolic Stage 2 Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update showing results for nebivolol in patients with systolic stage 2 hypertension; the study status is COMPLETED and results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Bystolic) (nebivolol)

Snippet

Sponsor: Forest Laboratories | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2012-01-11